Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
Blog Home
Bob Carey
Chief Market Strategist
Click for Bio

Follow Bob on Twitter Follow Bob on LinkedIn View Videos on YouTube

  US Stock Markets Ended June 19, 2020
Posted Under: Weekly Market Commentary
Supporting Image for Blog Post

Last week, equities rallied as fears of a second wave of COVID-19 abated. The S&P 500 Index finished up 1.9% as Health Care and Information Technology names helped buoy equities. Since the top of the index on 2/19/2020 Information Technology has been the top sector and Health Care the fourth best sector in the index. That lead to Momentum being the top factor last week and almost on cue Value being the worst performing factor last week. As the equity market continues to adjust to the fallout of the COVID-19 recession, factor volatility remains high. Month over month retail sales grew 17.7% in May, crushing the 8.4% estimates from economists and marked the highest month on record. Understandably this followed April retail sales plummet of 14.7%, the worst month on record. Retail sales roaring back adds more evidence that a V shape recovery is possible as more states continue their efforts to further open. Not everything is opening soon, the Cruise Lines International Association announced cruises out of US ports are suspended until September 15th, this sent Carnival Corp, Norwegian Cruise Line and Royal Caribbean all down over 5% last week. Eli Lilly & Co jumped over 15% on Tuesday after announcing very positive phase 3 results on the breast cancer drug Verzenio. Additional positive cancer drug news came from Jazz Pharmaceuticals as they rallied nearly 9% after the FDA approved Zepzelca for metastatic small cell lung cancer. Looking ahead to next week, headlines on the COVID pandemic are likely to drive equity market returns. There have been several states (Florida, Texas, Arizona and California among others) where cases have been accelerating but further data is needed to determine if there will be an additional wave of hospitalizations. 
Posted on Monday, June 22, 2020 @ 8:22 AM • Post Link Share: 
Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
Market Commentary and Analysis
Market Commentary Video
Weekly Market Commentary
Weekly Market Watch
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email

US Economy and Credit Markets Ended June 19, 2020
A Snapshot of Health Care Stocks
A Snapshot Of Equity Fund Flows
US Stock Markets Ended June 12, 2020
US Economy and Credit Markets Ended June 12, 2020
This Covered Call Index Tends To Outperform The S&P 500 When Stock Returns Are Modest Or Negative
S&P 500 Index Dividend Payout Profile
US Stock Markets Ended June 8, 2020
US Economy and Credit Markets Ended June 8, 2020
The Buy And Hold Investment Strategy Is Not Dead!
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2023 All rights reserved.